- Home
- SIMO vs TARS Comparison
SIMO vs TARS Comparison
Compare SIMO & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIMO
- TARS
- Stock Information
- Founded
- SIMO 1995
- TARS 2016
- Country
- SIMO Hong Kong
- TARS United States
- Employees
- SIMO N/A
- TARS N/A
- Industry
- SIMO Semiconductors
- TARS Medicinal Chemicals and Botanical Products
- Sector
- SIMO Technology
- TARS Health Care
- Exchange
- SIMO Nasdaq
- TARS Nasdaq
- Market Cap
- SIMO 2.9B
- TARS 2.8B
- IPO Year
- SIMO 2005
- TARS 2020
- Fundamental
- Price
- SIMO $84.33
- TARS $79.00
- Analyst Decision
- SIMO Strong Buy
- TARS Strong Buy
- Analyst Count
- SIMO 8
- TARS 8
- Target Price
- SIMO $103.13
- TARS $73.63
- AVG Volume (30 Days)
- SIMO 477.8K
- TARS 472.3K
- Earning Date
- SIMO 10-30-2025
- TARS 11-04-2025
- Dividend Yield
- SIMO 2.36%
- TARS N/A
- EPS Growth
- SIMO 8.75
- TARS N/A
- EPS
- SIMO 2.87
- TARS N/A
- Revenue
- SIMO $798,326,000.00
- TARS $366,100,000.00
- Revenue This Year
- SIMO $7.44
- TARS $139.46
- Revenue Next Year
- SIMO $17.57
- TARS $49.91
- P/E Ratio
- SIMO $29.21
- TARS N/A
- Revenue Growth
- SIMO N/A
- TARS 182.44
- 52 Week Low
- SIMO $37.21
- TARS $38.51
- 52 Week High
- SIMO $106.60
- TARS $83.47
- Technical
- Relative Strength Index (RSI)
- SIMO 40.83
- TARS 64.21
- Support Level
- SIMO $79.76
- TARS $73.86
- Resistance Level
- SIMO $84.98
- TARS $82.42
- Average True Range (ATR)
- SIMO 4.33
- TARS 3.75
- MACD
- SIMO -1.02
- TARS 0.54
- Stochastic Oscillator
- SIMO 23.43
- TARS 75.20
About SIMO Silicon Motion Technology Corporation
Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.